Brief: Acumen Presents Poster Describing Method To Standardize Amyloid Beta Oligomer Assays Supporting Therapeutic Development For Early Alzheimer’S Disease

Acumen Pharmaceuticals

01/08/2022 17:15

Acumen Pharmaceuticals Inc  ABOS.O :
    * ACUMEN PRESENTS POSTER DESCRIBING METHOD TO STANDARDIZE
AMYLOID
BETA OLIGOMER ASSAYS SUPPORTING THERAPEUTIC DEVELOPMENT FOR
EARLY ALZHEIMER’S DISEASE

Source text for Eikon:  ID:nGNX672NtD 
Further company coverage:  ABOS.O